Results

eNauka >  Results >  Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer - the X-ACT trial
Title: Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer - the X-ACT trial
Authors: Cassidy, J.; Douillard, Y.; Twelves, C.; McKendrick, J. J.; Scheithauer, W.; Bustova, I.; Johnston, P. G.; Lesniewski-Kmak, L.; Jelić, Svetislav  ; Fountzilas, G.;
Coxon, F.; Diaz-Rubio, E.; Maughan, T. S.; Malzyner, A.; Bertetto, O.; Beham, A.; Figer, A.; Dufour, P.; Patel, K. K.; Cowell, W.; Garrison, L. P.;
Issue Date: 2006
Publication: British Journal of Cancer
ISSN: 0007-0920 British Journal of Cancer Search Idenfier
Publisher: Houndmills : H Holt MacMillan Journals
Type: Article
Collation: vol. 94 br. 8 str. 1122-1129
DOI: 10.1038/sj.bjc.6603059
WoS-ID: 000236910300006
Scopus-ID: 2-s2.0-33646142547
PMID: 16622438
PMCID: PMC2361258
VBS COBISS: 1026712757
URI: https://plus.cobiss.net/cobiss/sr/sr/bib/1026712757#izum.si
https://enauka.gov.rs/handle/123456789/645569
M-category: 
21M21

116
SCOPUSTM
45
PubMed CentralTM
83
OpenCitations
98
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.